676 / 1708
Treatment proposal according to the EuroNet PHL C2 Study
TL2: Stage I and IIB with risk factors
At time of diagnosis
ERA
LRA
2x OEPA
2x COPDAC-28
ERA PET positive
primary Tumor extension without boost
|
|
676 / 1708
Treatment proposal according to the EuroNet PHL C2 Study
TL2: Stage I and IIB with risk factors
At time of diagnosis
ERA
LRA
2x OEPA
2x COPDAC-28
ERA PET positive
primary Tumor extension without boost